Keros Therapeutics Inc (KROS)
US$ 11.84-1.5%
Price Chart
Key Statistics
Market Cap
$ 570.24M
P/E Ratio
0.00
Revenue (TTM)
$ 214.71M
Volume
1.47M
52W High
$ 72.37
52W Low
$ 9.12
Dividend Yield
0.00%
Beta
1.32
Technicals
50-Day MA
12.5942
200-Day MA
32.5479
52 Week High
72.37
52 Week Low
9.12
About KROS
Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops and commercializes novel therapeutics for patients with disorders that are linked to dysfunctional signaling of the trans.
Employees
163
Headquarters
Lexington, MA
CEO
Dr. Jasbir S. Seehra Ph.D.
Latest News
WWE Superstar Karrion Kross Addresses Logan Paul Criticism - Newsweek
9 hours ago • Google News
Karrion Kross Gives an Update on His WWE Future - Athlon Sports
9 hours ago • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg